Quick Answer
Genvor Inc reported Diluted EPS of $0.22 per share (loss) for fiscal year 2025.
Genvor Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.22 | -46.7% |
| 2024 | -$0.15 | -66.7% |
| 2023 | -$0.09 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.02 | +91.7% | -100.0% |
| June 30, 2025 | -$0.01 | +66.7% | +0.0% |
| March 31, 2025 | -$0.01 | +75.0% | +95.8% |
| December 31, 2024 | -$0.24 | -242.9% | -700.0% |
| June 30, 2024 | -$0.03 | -200.0% | +25.0% |
| March 31, 2024 | -$0.04 | -300.0% | +42.9% |
| December 31, 2023 | -$0.07 | -600.0% | -600.0% |
| June 30, 2023 | -$0.01 | +50.0% | +0.0% |
- Genvor Inc showed a decrease of -46.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Genvor Inc’s diluted eps has declined by 144.4% (from $0.09 per share (loss) to $0.22 per share (loss)).
- The most recent figure is from Genvor Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 10, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: